[{"Assets_0_FY_USD":624087000.0,"CommonStockSharesOutstanding_0_FY_shares":122280092.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-111767000.0,"NetIncomeLoss_1_FY_USD":-49774000.0,"NetIncomeLoss_4_FY_USD":-203540000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":121552000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":106150000.0,"StockholdersEquity_0_FY_USD":209472000.0,"EarningsPerShareBasic_1_FY_USD":-0.41,"EarningsPerShareBasic_4_FY_USD":-1.92,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190315"}]